Which Behavior of Myomatous masses is Diagnostic for Leiomyosarcoma: How Do You Clinically Differentiate Between Leiomyoma and Leiomyosarcoma? A Case Report

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 42

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JOGCR-9-4_017

تاریخ نمایه سازی: 10 مرداد 1403

Abstract:

Distinguishing between leiomyosarcoma and benign uterine leiomyoma, as one of the common problems in reproductive age, brings a great challenge in dealing with patients. Clinical findings, imaging report, tumor markers, endometrial biopsy, and even age of the patients will not be helpful to make this distinction. So, the important question is when we should consider leiomyosarcoma probability? In this report, an unexpected case of leiomyosarcoma with a poor prognosis is presented. A ۴۵-year-old female patient gravida ۳ with complaint of hypermenorrhea from one year ago was presented to the gynecologic department. The patient did not mention anything special in her medical history. At last, a hysterectomy was planned due to her irreversible bothering symptom. The final histologic report was leiomyosarcoma in the smallest myomatous mass of the uterus, and her post-operation CT scan with contrast of abdomen-pelvic revealed several metastatic focuses. Uterine sarcomas as one of the most important causes of mortality worldwide have a low incidence and defining the standard treatment and the exact prognosis require further study. More definitive ways to differentiate benign uterine leiomyoma from leiomyosarcoma including genetic studies, specific imaging techniques, specific tumor markers, and investigating the method of intrauterine biopsy by flexible or robotic hysteroscopy are needed.

Authors

Leila Mousavi Seresht

Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Amir Reza Farhadi Dehkordi

Research Student, Isfahan University of Medical Sciences, Isfahan, Iran

Azar Danesh Shahraki

Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Fereshteh Mohammadizadeh

Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Fedyeh Haghollahi

Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Pritts EA, Vanness DJ, Berek JS, Parker W, Feinberg R, ...
  • Zappacosta R, Fanfani F, Zappacosta B, Sablone F, Pansa L, ...
  • Santos P, Cunha TM. Uterine sarcomas: clinical presentation and MRI ...
  • Salman S, Ketenci Gencer F, Babaoğlu B, Bestel M, Kumbasar ...
  • Behtash N, Akhavan S. The outcomes of uterine sarcoma: A ...
  • Brohl AS, Li L, Andikyan V, Običan SG, Cioffi A, ...
  • Berger-Richardson D, Swallow CJ. Needle tract seeding after percutaneous biopsy ...
  • Robertson EG, Baxter G. Tumour seeding following percutaneous needle biopsy: ...
  • Cao H, Li L, Yang B, Luo G, Lou J, ...
  • Martin-Liberal J. Leiomyosarcoma: Principles of management. Intractable Rare Dis Res. ...
  • Hoang HL, Ensor K, Rosen G, Leon Pachter H, Raccuia ...
  • نمایش کامل مراجع